USNA
USANA Health Sciences, Inc.
USNA lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to fall sharply.
USNA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
USNA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
USNA PE Valuation
USNA has no meaningful PE right now: it lost money over the past year.
USNA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect USNA's earnings and profitability to decline, with its revenue holding steady.
USNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.01 | — |
| Q3 2026 | -$1.12 | -227% |
| Q2 2026 | -$1.18 | -166% |
| Q1 2026 | $0.50 | -73% |
| Q4 2025 | $0.58 | -74% |
| Q3 2025 | $0.88 | -69% |
| Q2 2025 | $1.80 | -37% |
| Q1 2025 | $1.82 | -43% |
| Q4 2024 | $2.19 | -34% |
USNA has swung to a loss: it lost $1.12 per share over the past year, after a profit the year before.
USNA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $205.9M | -3.6% |
| Q2 2026 | $223.3M | -5.3% |
| Q1 2026 | $250.2M | +0.3% |
| Q4 2025 | $226.2M | +5.9% |
| Q3 2025 | $213.7M | +6.7% |
| Q2 2025 | $235.8M | +11% |
| Q1 2025 | $249.5M | +9.5% |
| Q4 2024 | $213.6M | -3.4% |
USNA's revenue fell from its 2021 peak and has held roughly level since: $206M last quarter, down 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.7% | -1.3 points |
| Q2 2026 | -9% | -16 points |
| Q1 2026 | 5.5% | -0.7 points |
| Q4 2025 | 1.7% | -2.1 points |
| Q3 2025 | 0.6% | -7.2 points |
| Q2 2025 | 7.1% | -1.3 points |
| Q1 2025 | 6.3% | -4.5 points |
| Q4 2024 | 3.8% | -7.1 points |
USNA's operating margin was −0.7% last quarter, down 1.3 points from the same quarter a year ago, near the bottom of its range since 2019.
USNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.4M | +$13.6M |
| Q2 2026 | $20.2M | +180% |
| Q1 2026 | $7.1M | -44% |
| Q4 2025 | -$6.2M | -255% |
| Q3 2025 | -$5.2M | -119% |
| Q2 2025 | $7.2M | +35% |
| Q1 2025 | $12.7M | -12% |
| Q4 2024 | $4M | -79% |
USNA still generates free cash flow, though less than at its 2019 peak: $30M over the past year.
USNA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -6.2x | Net Cash |
| Q2 2026 | -5.4x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
USNA has more cash than debt.
USNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 10.5 | Oversold |
USNA's weekly RSI is 34 (neutral) and its Stochastic is 11 (oversold).
USNA PE vs Consumer Defensive Sector
| Metric | USNA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
USNA has no meaningful PE right now: it lost money over the past year.
USNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.3 | 11% below |
| 20 week MA | $16.2 | 21% below |
| 50 week MA | $18.2 | 30% below |
| 100 week MA | $23.5 | 46% below |
| 200 week MA | $37.5 | 66% below |
USNA is in a downtrend: it's below all five of its weekly moving averages, and 66% below its 200-week average.
USNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $77.8 | -2.8% |
| 2021 | $77.8 | $100.5 | +29% |
| 2022 | $100.5 | $54.4 | -46% |
| 2023 | $54.4 | $53.6 | -1.5% |
| 2024 | $53.6 | $35.7 | -33% |
| 2025 | $35.7 | $19.8 | -44% |
| 2026 YTD | $19.8 | $12.7 | -36% |
USNA has finished four years in a row lower, and it's down 36% so far in 2026.